Researchers Make Headway in Treatment of Diabetic Retinopathy
...ological targets. One study mentioned within the article was led by Dr. Lloyd Aiello of the Joslin Diabetes Center, who showed that the compound ruboxistaurin slowed the progress of retinopathy by inhibiting an enzyme in the body called protein kinase C beta (PKC beta), which is believed to contribute to the...Ruboxistaurin As A Novel Treatment For Diabetic Nephropathy
...in the current issue of Diabetes Care, establishes ruboxistaurin as a promising novel treatment that may improve up...KC)-? in the pathogenesis of diabetic nephropathy. ruboxistaurin selectively inhibits protein kinase C-? and amelio... was performed to evaluate the effects of 32mg/day ruboxistaurin for 1 year in persons with type 2 diabetes and per...Ruboxistaurin (RBX) may prevent vision loss in diabetic patients
... Phase III clinical trial of ruboxistaurin (RBX) at a concentration of 32 milligrams/day// was found to inhibit Protein kinase C (PKC) – beta inhibitor, which was found to cause vision loss in ...